Status:
COMPLETED
Urine Albendazole Levels for Coverage Assessment
Lead Sponsor:
Universidad Nacional de Salta
Collaborating Sponsors:
Fundacion Mundo Sano
CIVETAN-Tandil, UNCPBA
Conditions:
Helminthiasis
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This project will develop and assess the feasibility and acceptability of a urine-based assay to monitor adherence to Mass Drug Administration (MDA) campaigns within Soil-transmitted helminthiasis (ST...
Detailed Description
Soil-Transmitted-Helminthic (STH) infections are a major public health issue affecting the world's poorest populations. Control strategies for STH have been focused on the use of mass chemotherapy oft...
Eligibility Criteria
Inclusion
- Body Mass Index: 18 to 25.
- Physical exam without significant abnormal findings
Exclusion
- Pregnancy
- Lactation
- Use of ABZ or other benzimidazole drugs in the previous 30 days.
- History of intolerance to ABZ.
- Malabsorption and/or other gastrointestinal conditions that might compromise ABZ absorption.
Key Trial Info
Start Date :
July 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04041427
Start Date
July 17 2019
End Date
February 28 2020
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Investigaciones de Enfermedades Tropicales, UNSalta
Orán, Salta Province, Argentina, 4530